https://doi.org/10.4081/mm.2024.13227

Evaluation of ceftazidime-avibactam resistance in clinical isolates of Enterobacterales from a large tertiary-care hospital, Italy, 2019-2023

Vol. 39 No. 2 (2024)
Published: 3 December 2024
Abstract Views: 24
PDF: 19
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

L. Calabrese
lucacala1998@gmail.com
Department of Surgical Sciences and Integrated Diagnostics,University of Genoa, Genoa; Microbiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
E. Willison
Microbiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
G. Codda
Department of Surgical Sciences and Integrated Diagnostics,University of Genoa, Genoa, Italy.
E. Costa
Department of Surgical Sciences and Integrated Diagnostics,University of Genoa, Genoa; Microbiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
V. Di Pilato
Department of Surgical Sciences and Integrated Diagnostics,University of Genoa, Genoa, Italy.
A. Marchese
Department of Surgical Sciences and Integrated Diagnostics,University of Genoa, Genoa; Microbiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Not available.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Potter RF, D'Souza AW, Dantas G. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resist Updat. 2016;29:30-46. doi:10.1016/j.drup.2016.09.002 DOI: https://doi.org/10.1016/j.drup.2016.09.002
Doi Y. Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections. Clin Infect Dis. 2019;69(Suppl 7):S565-S575. doi:10.1093/cid/ciz830 DOI: https://doi.org/10.1093/cid/ciz830
Zhang P, Shi Q, Hu H, et al. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Clin Microbiol Infect. 2020;26(1):124.e1-124.e4. doi:10.1016/j.cmi.2019.08.020 DOI: https://doi.org/10.1016/j.cmi.2019.08.020
Bonomo RA, Burd EM, Conly J, et al. Carbapenemase-Producing Organisms: A Global Scourge. Clin Infect Dis. 2018;66(8):1290-1297. doi:10.1093/cid/cix893 DOI: https://doi.org/10.1093/cid/cix893
Carattoli A, Arcari G, Bibbolino G, et al. Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates. Antimicrob Agents Chemother. 2021;65(10):e0057421. doi:10.1128/AAC.00574-21 DOI: https://doi.org/10.1128/AAC.00574-21
Hernández-Allés S, Benedí VJ, Martínez-Martínez L, et al. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob Agents Chemother. 1999;43(4):937-939. doi:10.1128/AAC.43.4.937 DOI: https://doi.org/10.1128/AAC.43.4.937

How to Cite

Calabrese, L., Willison, E., Codda, G., Costa, E., Di Pilato, V., & Marchese, A. (2024). Evaluation of ceftazidime-avibactam resistance in clinical isolates of Enterobacterales from a large tertiary-care hospital, Italy, 2019-2023. Microbiologia Medica, 39(2). https://doi.org/10.4081/mm.2024.13227
Copyright (c) 2024 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.